COTA
Founded by oncologists and data scientists, COTA, Inc. builds solutions that analyze
real-world evidence and deliver clinically relevant insights to improve cancer care.
The Company partners with providers, payers, and life science companies involved in
diagnosing and treating complex diseases to optimize the outcomes of individual
patients and lower overall healthcare costs. Through its EMR-agnostic patented
COTA Nodal Address® (CNA) system, a unique digital classification methodology
that stratifies patients into distinct cohorts, COTA is enabling precision medicine at
scale.